Dyne Therapeutics (DYN) Interest Expenses (2025)

Dyne Therapeutics (DYN) recorded quarterly Interest Expenses of $2.9 million in Q3 2025, up 2989.36% quarter-over-quarter from $94000.0 in Q2 2025.

Dyne Therapeutics (DYN) Interest Expenses (2025) Analysis & Trends

Dyne Therapeutics' Interest Expenses history runs 1 years deep, the most recent figure standing at $2.9 million for Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Expense (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	-
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	-5.50 Mn
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	61,000.00
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-332,000.00
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-2,753.00
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	-
9	Abivax	90.15 Bn	90.15 Bn	-	-5.58 Mn
10	Dyne Therapeutics	3.00 Bn	3.00 Bn	-	-

Download Data